Clinical trial
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy of EQ-778 on Upper Respiratory Tract Health Status in Healthy Adults
NCT05835375 is registered in ClinicalTrials.gov with Vedic Lifesciences Pvt. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy of EQ-778 on Upper Respiratory Tract Health Status in Healthy Adults
- Lead sponsor
- Vedic Lifesciences Pvt. Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 2, 2023
- Completion date
- April 26, 2024
- Enrollment
- 374 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
upper respiratory tract infection